Year of programme | Â | Year 1 | Year 10 | |||||
---|---|---|---|---|---|---|---|---|
Screening scenario | Â | gFOBT | FIT | FSIG | gFOBT | FIT | FSIG | |
Screening-related resource use | ||||||||
Screening tests | No. of kits sent out | 357,812 | 357,812 | Â | 420,151 | 417,464 | Â | |
No. of kits processed | 189,640 | 189,640 | Â | 222,637 | 220,999 | Â | ||
No. of FSIG done1 | Â | Â | 18,617 | Â | Â | 20,625 | ||
COL/CTC | No. of diagnostic COL | 967 | 11,095 | 381 | 1,103 | 12,414 | 423 | |
No. of diagnostic CTC | 126 | 1,442 | 50 | 143 | 1,614 | 55 | ||
No. of surveillance COL | 0 | 0 | 0 | 297 | 2,406 | 620 | ||
No. of surveillance CTC | 0 | 0 | 0 | 39 | 313 | 81 | ||
Pathology | No. of adenomas and CRCs requiring pathology2 | 1,004 | 7,161 | 1,599 | 1,356 | 8,909 | 2,222 | |
CRC work-up and treatment | No. receiving PET scan | 31 | 85 | 6 | 34 | 69 | 8 | |
No. receiving MRI scan | 111 | 307 | 23 | 121 | 247 | 28 | ||
No. receiving CT scan(s) | 309 | 853 | 64 | 336 | 687 | 78 | ||
No. receiving TUS | 16 | 43 | 3 | 17 | 35 | 4 | ||
No. receiving pre-operative radiotherapy3 | 71 | 196 | 15 | 75 | 146 | 17 | ||
No. undergoing colorectal resection4 | 281 | 779 | 59 | 307 | 635 | 71 | ||
Screening-related health outcomes | ||||||||
Harms 5 | No. with major bleeding following endoscopy | 4 | 48 | 7 | 6 | 62 | 10 | |
No. with perforation following endoscopy | 2 | 21 | 1 | 2 | 27 | 2 | ||
No. of deaths from perforation following endoscopy | 0 | 1 | 0 | 0 | 1 | 0 | ||
Screen-detected lesions | No. with adenoma(s)6 | Total | 366 | 3,320 | 808 | 537 | 4,327 | 1,128 |
  low-risk |  | 229 | 2,081 | 544 | 333 | 2,770 | 740 | |
  intermediate/high-risk |  | 137 | 1,239 | 264 | 204 | 1,558 | 388 | |
No. with CRC7 | Total | 309 | 853 | 64 | 336 | 687 | 78 | |
  stage I |  | 111 | 308 | 23 | 130 | 303 | 31 | |
  stage II |  | 105 | 293 | 22 | 115 | 237 | 26 | |
  stage III |  | 69 | 192 | 14 | 68 | 115 | 16 | |
  stage IV |  | 24 | 60 | 4 | 23 | 31 | 5 |